Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas
Mark A. Atkinson, Raghavendra G. Mirmira
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1500-1518
Open Access | Times Cited: 45
Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Sean T. Carey, Christopher Bridgeman, Christopher M. Jewell
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 17
Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment
Kazem Mashayekhi, Khashayarsha Khazaie, William A. Faubion, et al.
Bioactive Materials (2024) Vol. 37, pp. 269-298
Open Access | Times Cited: 5
Design Principles for Immunomodulatory Biomaterials
Samuel Abidemi Oluwole, Welday Desta Weldu, Keerthana Jayaraman, et al.
ACS Applied Bio Materials (2024)
Closed Access | Times Cited: 5
Local delivery strategies to restore immune homeostasis in the context of inflammation
Elizabeth R. Bentley, Steven R. Little
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113971-113971
Open Access | Times Cited: 28
Immunomodulatory nano-preparations for rheumatoid arthritis
Chenglong Li, Yangyun Han, Xianjin Luo, et al.
Drug Delivery (2022) Vol. 30, Iss. 1, pp. 9-19
Open Access | Times Cited: 19
Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation
Yang Yang, Pere Santamaría
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113898-113898
Open Access | Times Cited: 18
Engineering antigen-presenting cells for immunotherapy of autoimmunity
Clinton Smith, Zhenyu Wang, Jamal S. Lewis
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115329-115329
Closed Access | Times Cited: 2
Biomaterials‐based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents
Gregory P. Marshall, Judit Cserny, Chun‐Wei Wang, et al.
Journal of Biomedical Materials Research Part A (2022) Vol. 111, Iss. 2, pp. 185-197
Open Access | Times Cited: 8
Particle-Based therapies for antigen specific treatment of type 1 diabetes
Nicole Rose Lukesh, Denzel D. Middleton, Eric M. Bachelder, et al.
International Journal of Pharmaceutics (2022) Vol. 631, pp. 122500-122500
Open Access | Times Cited: 7
Design principles of microparticle size and immunomodulatory factor formulation dictate antigen-specific amelioration of multiple sclerosis in a mouse model
Alexander J. Kwiatkowski, Eric Y. Helm, Joshua M. Stewart, et al.
Biomaterials (2023) Vol. 294, pp. 122001-122001
Open Access | Times Cited: 2
Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomes
Yang Yang, Pere Santamaría
Current Opinion in Biotechnology (2022) Vol. 74, pp. 285-292
Closed Access | Times Cited: 4
Nano‐ and Microscale Drug Delivery Approaches for Therapeutic Immunomodulation
Juan L. Paris, Alejandro Baeza
ChemNanoMat (2021) Vol. 7, Iss. 7, pp. 773-788
Closed Access | Times Cited: 5
A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action
Sabine Arve-Butler, Cody D. Moorman
Frontiers in Immunology (2024) Vol. 15
Open Access
In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunities
Clémentine Halliez, Hazem Ibrahim, Timo Otonkoski, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 1
Vitamin D and type 1 diabetes
Pieter-Jan Martens, Conny Gysemans, Chantal Mathieu
Elsevier eBooks (2023), pp. 1109-1128
Closed Access | Times Cited: 1
The type 1 diabetes immune niche: Immunomodulatory biomaterial design considerations for beta cell transplant therapies
Claire E. Hilburger, Matthew Rosenwasser, Derfogail Delcassian
Journal of Immunology and Regenerative Medicine (2022) Vol. 17, pp. 100063-100063
Closed Access | Times Cited: 2
Insight of Engineered Nano-based Biologics Approaches used to Combat Autoimmune Disease using TNF-α & IL Inhibitors
Darshani Patil, M. Ajazuddin, Sankha Bhattacharya
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 19, pp. 1793-1806
Closed Access
Regulation of Antigen‐Specific Immunotherapy with Nanomaterials
Weifan Ye, Yiwen Jia, Hongze Ren, et al.
Advanced NanoBiomed Research (2023) Vol. 3, Iss. 12
Open Access
Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents
Irina O. Chikileva, И. Ж. Шубина, Anzhelika-Mariia Burtseva, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 868-868
Open Access
Modern antiviral biomedical cell products and their applications for COVID-19 therapy
Irina O. Chikileva, И. Ж. Шубина, M. V. Kiselevskiy
Russian Journal of Biotherapy (2022) Vol. 21, Iss. 2, pp. 19-32
Closed Access
GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations
Matthew R. Carstens, Clive Wasserfall, Abhinav P. Acharya, et al.
Lab on a Chip (2021) Vol. 21, Iss. 18, pp. 3598-3613
Open Access
Page 1

Scroll to top